This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2010 Remove FDA Remove Pharmaceutical Remove Pharmaceutical products
article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

MARCH 11, 2024

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. In summary, considering the serious diseases caused by contaminated pharmaceuticals and the challenges discussed, Ahmed et al.

Pharmaceutical 82
Pharmaceutical Food and Drug Administration Manufacturing Pharmaceutical products 82
article thumbnail

Global comparator data signal “alarm bells” for UK Government, says APBI

pharmaphorum

JULY 27, 2022

Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”. Access to medicines. Clinical trials and exports. in the same period.

Government 88
Government Recruitment Medicine Competition 88
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024